BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12402592)

  • 1. Influence of the preceding exchange on peritoneal equilibration test results.
    Figueiredo AE; Conti A; Poli de Figueiredo CE
    Adv Perit Dial; 2002; 18():75-7. PubMed ID: 12402592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short peritoneal equilibration test: impact of preceding dwell time.
    Twardowski ZJ; Prowant BF; Moore HL; Lou LC; White E; Farris K
    Adv Perit Dial; 2003; 19():53-8. PubMed ID: 14763034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in peritoneal equilibration test results in patients aged above or below 60 years.
    Grzegorzewska AE; Leander M; Mariak I
    Adv Perit Dial; 2002; 18():33-9. PubMed ID: 12402583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term effects of single peritonitis episodes on peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients.
    Hung SY; Chung HM
    Adv Perit Dial; 2001; 17():196-9. PubMed ID: 11510273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of body size indices, residual renal function, and peritoneal transport characteristics in continuous ambulatory peritoneal dialysis.
    Twardowski ZJ; Moore HL; Prowant BF; Satalowich R
    Adv Perit Dial; 2009; 25():155-64. PubMed ID: 19886338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the dialysis adequacy and transport test in peritoneal dialysis.
    Seo JJ; Kim YL; Park SH; Kim CD; Kim JC; Jang MH; Choi HJ
    Adv Perit Dial; 2005; 21():25-30. PubMed ID: 16686280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating glucose absorption in peritoneal dialysis using peritoneal equilibration tests.
    Bodnar DM; Busch S; Fuchs J; Piedmonte M; Schreiber M
    Adv Perit Dial; 1993; 9():114-8. PubMed ID: 8105902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of peritoneal membrane assessed before and after the start of peritoneal dialysis.
    La Milia V; Limardo M; Cavalli A; Crepaldi M; Locatelli F
    Nephrol Dial Transplant; 2009 Sep; 24(9):2894-8. PubMed ID: 19349295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of peritoneal solute transfer by the peritoneal equilibration test in children.
    Schaefer F; Langenbeck D; Heckert KH; Schärer K; Mehls O
    Adv Perit Dial; 1992; 8():410-5. PubMed ID: 1361835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adequacy of dialysis in CAPD and cycler PD; the PET is enough.
    Wolf CJ; Polsky J; Ntoso KA; Koethe JD; Gerhardt RE
    Adv Perit Dial; 1992; 8():208-11. PubMed ID: 1361788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
    Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
    J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of peritoneal equilibration test with 2.27% and 3.86% glucose dialysis solution.
    Cara M; Virga G; Mastrosimone S; Girotto A; Rossi V; D'Angelo A; Bonfante L
    J Nephrol; 2005; 18(1):67-71. PubMed ID: 15772925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.
    Clerbaux G; Francart J; Wallemacq P; Robert A; Goffin E
    Nephrol Dial Transplant; 2006 Apr; 21(4):1032-9. PubMed ID: 16364990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The peritoneal transport type might be distinctive among different Mexican populations on CAPD].
    Rojas-Campos E; Martínez-Ramírez HR; Cortés-Sanabria L; González L; Martín-del-Campo F; Monteón-Ramos F; Gómez-Navarro B; Cueto-Manzano AM
    Rev Invest Clin; 2008; 60(4):284-91. PubMed ID: 18956549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperhomocysteinemia in CAPD patients: peritoneal transport of total homocysteine at peritoneal equilibration test and daily elimination of total homocysteine].
    Hirose S; Kono R; Mitarai T; Isoda K; Kim S; Shimoyama H
    Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):778-86. PubMed ID: 10655726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistency of the peritoneal equilibration test in a cohort of nonselected Mexican CAPD patients.
    Cueto-Manzano AM; Gamba G; Abasta-Jiménez M; Correa-Rotter R
    Adv Perit Dial; 1995; 11():114-8. PubMed ID: 8534682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in peritoneal membrane transport rates in patients on long term CAPD.
    Blake PG; Abraham G; Sombolos K; Izatt S; Weissgarten J; Ayiomamitis A; Oreopoulos DG
    Adv Perit Dial; 1989; 5():3-7. PubMed ID: 2577421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two years on continuous ambulatory peritoneal dialysis--does it change peritoneal transport?
    Kaczmarek EE; Grzegorzewska AE
    Adv Perit Dial; 2004; 20():2-7. PubMed ID: 15384785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the preceding exchange on peritoneal equilibration test results: a prospective study.
    Lilaj T; Vychytil A; Schneider B; Hörl WH; Haag-Weber M
    Am J Kidney Dis; 1999 Aug; 34(2):247-53. PubMed ID: 10430970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.